Recent advancements around pTau217 assays are drawing significant attention for their ability to detect amyloid pathology through minimally invasive blood testing...
The designation supports Gene Solutions’ US development pathway for its multi-omic blood-based test designed to detect cancer-associated signals across 10 cancer types. ...
Fully integrated for use with the Varian Eclipse treatment planning system to automate routine contouring ...
With a differentiated approach to calcium modification, AVS aims to simplify peripheral vascular interventions while enhancing procedural outcomes and patient safety...
Hypertension is considered one of the leading preventable causes of premature death all across the world...
RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
Expansion of Vanquish procedures highlights growing adoption of minimally invasive water vapour ablation technology for prostate disease ...
Together, these announcements represent a step forward in increasing accessibility to complex DNA...
